Data as of Mar 07
| -0.58 / -1.11%|
The 11 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 57.00, with a high estimate of 64.00 and a low estimate of 44.00. The median estimate represents a +10.77% increase from the last price of 51.46.
The current consensus among 15 polled investment analysts is to Buy stock in AbbVie Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.